vs
CRYO CELL INTERNATIONAL INC（CCEL）与FIRST US BANCSHARES, INC.（FUSB）财务数据对比。点击上方公司名可切换其他公司
FIRST US BANCSHARES, INC.的季度营收约是CRYO CELL INTERNATIONAL INC的1.3倍（$10.4M vs $7.8M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -48.7%，领先69.1%），FIRST US BANCSHARES, INC.同比增速更快（7.1% vs -2.3%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $1.2M），过去两年FIRST US BANCSHARES, INC.的营收复合增速更高（2.6% vs -0.1%）
Cryo-Cell国际是一家脐带血库企业，由丹·理查德于1989年创立，是全球首家分离并储存干细胞的民营脐带血库，总部位于佛罗里达州奥兹马尔，地处坦帕市郊。
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
CCEL vs FUSB — 直观对比
营收规模更大
FUSB
是对方的1.3倍
$7.8M
营收增速更快
FUSB
高出9.3%
-2.3%
净利率更高
FUSB
高出69.1%
-48.7%
自由现金流更多
FUSB
多$7.9M
$1.2M
两年增速更快
FUSB
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.8M | $10.4M |
| 净利润 | $-3.8M | $2.1M |
| 毛利率 | 77.9% | — |
| 营业利润率 | -50.6% | 28.1% |
| 净利率 | -48.7% | 20.4% |
| 营收同比 | -2.3% | 7.1% |
| 净利润同比 | -105.1% | 24.2% |
| 每股收益（稀释后） | $-0.46 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCELFUSB
| Q4 25 | $7.8M | $10.4M | ||
| Q3 25 | $7.8M | $10.5M | ||
| Q2 25 | $7.9M | $10.3M | ||
| Q1 25 | $8.0M | $9.8M | ||
| Q4 24 | $8.0M | $9.7M | ||
| Q3 24 | $8.1M | $10.1M | ||
| Q2 24 | $8.0M | $10.0M | ||
| Q1 24 | $7.9M | $9.9M |
净利润CCELFUSB
| Q4 25 | $-3.8M | $2.1M | ||
| Q3 25 | $749.4K | $1.9M | ||
| Q2 25 | $355.8K | $155.0K | ||
| Q1 25 | $282.9K | $1.8M | ||
| Q4 24 | $-1.9M | $1.7M | ||
| Q3 24 | $1.1M | $2.2M | ||
| Q2 24 | $655.8K | $2.1M | ||
| Q1 24 | $556.2K | $2.1M |
毛利率CCELFUSB
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 76.6% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
营业利润率CCELFUSB
| Q4 25 | -50.6% | 28.1% | ||
| Q3 25 | 24.3% | 23.9% | ||
| Q2 25 | 18.8% | 1.6% | ||
| Q1 25 | 13.3% | 23.8% | ||
| Q4 24 | -1.5% | 23.8% | ||
| Q3 24 | 17.2% | 29.2% | ||
| Q2 24 | 17.3% | 27.4% | ||
| Q1 24 | 10.5% | 27.8% |
净利率CCELFUSB
| Q4 25 | -48.7% | 20.4% | ||
| Q3 25 | 9.6% | 18.4% | ||
| Q2 25 | 4.5% | 1.5% | ||
| Q1 25 | 3.5% | 18.1% | ||
| Q4 24 | -23.2% | 17.6% | ||
| Q3 24 | 13.0% | 22.0% | ||
| Q2 24 | 8.2% | 21.2% | ||
| Q1 24 | 7.1% | 21.3% |
每股收益（稀释后）CCELFUSB
| Q4 25 | $-0.46 | $0.36 | ||
| Q3 25 | $0.09 | $0.32 | ||
| Q2 25 | $0.04 | $0.03 | ||
| Q1 25 | $0.03 | $0.29 | ||
| Q4 24 | $-0.23 | $0.29 | ||
| Q3 24 | $0.13 | $0.36 | ||
| Q2 24 | $0.08 | $0.34 | ||
| Q1 24 | $0.07 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $73.5M |
| 总债务越低越好 | $8.4M | $10.9M |
| 股东权益账面价值 | $-18.6M | $105.6M |
| 总资产 | $61.7M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资CCELFUSB
| Q4 25 | $3.3M | $73.5M | ||
| Q3 25 | $3.2M | $54.7M | ||
| Q2 25 | $4.4M | $54.0M | ||
| Q1 25 | $3.5M | $56.0M | ||
| Q4 24 | $3.5M | $47.2M | ||
| Q3 24 | $2.1M | $82.3M | ||
| Q2 24 | $1.5M | $58.2M | ||
| Q1 24 | $979.6K | $60.2M |
总债务CCELFUSB
| Q4 25 | $8.4M | $10.9M | ||
| Q3 25 | $8.4M | $10.9M | ||
| Q2 25 | $8.4M | $10.9M | ||
| Q1 25 | $8.5M | $10.9M | ||
| Q4 24 | $8.5M | $10.9M | ||
| Q3 24 | $8.5M | $10.9M | ||
| Q2 24 | $8.5M | $10.8M | ||
| Q1 24 | $8.6M | $10.8M |
股东权益CCELFUSB
| Q4 25 | $-18.6M | $105.6M | ||
| Q3 25 | $-14.8M | $104.2M | ||
| Q2 25 | $-15.6M | $101.9M | ||
| Q1 25 | $-14.7M | $101.2M | ||
| Q4 24 | $-13.2M | $98.6M | ||
| Q3 24 | $-9.6M | $98.5M | ||
| Q2 24 | $-10.7M | $93.8M | ||
| Q1 24 | $-10.3M | $92.3M |
总资产CCELFUSB
| Q4 25 | $61.7M | $1.2B | ||
| Q3 25 | $63.2M | $1.1B | ||
| Q2 25 | $64.4M | $1.1B | ||
| Q1 25 | $64.4M | $1.1B | ||
| Q4 24 | $64.7M | $1.1B | ||
| Q3 24 | $62.9M | $1.1B | ||
| Q2 24 | $62.6M | $1.1B | ||
| Q1 24 | $61.7M | $1.1B |
负债/权益比CCELFUSB
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $12.3M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | $9.1M |
| 自由现金流率自由现金流/营收 | 15.5% | 87.2% |
| 资本支出强度资本支出/营收 | 0.9% | 31.1% |
| 现金转化率经营现金流/净利润 | — | 5.79× |
| 过去12个月自由现金流最近4个季度 | $5.2M | $16.0M |
8季度趋势，按日历期对齐
经营现金流CCELFUSB
| Q4 25 | $1.3M | $12.3M | ||
| Q3 25 | $2.5M | $4.2M | ||
| Q2 25 | $707.0K | $3.9M | ||
| Q1 25 | $954.1K | $1.8M | ||
| Q4 24 | $2.2M | $7.8M | ||
| Q3 24 | $2.4M | $1.9M | ||
| Q2 24 | $1.8M | $2.5M | ||
| Q1 24 | $-356.9K | $825.0K |
自由现金流CCELFUSB
| Q4 25 | $1.2M | $9.1M | ||
| Q3 25 | $2.5M | $3.6M | ||
| Q2 25 | $644.6K | $1.6M | ||
| Q1 25 | $892.0K | $1.7M | ||
| Q4 24 | $2.1M | $5.7M | ||
| Q3 24 | $2.3M | $1.3M | ||
| Q2 24 | $21.5K | $2.3M | ||
| Q1 24 | $-814.6K | $-142.0K |
自由现金流率CCELFUSB
| Q4 25 | 15.5% | 87.2% | ||
| Q3 25 | 31.9% | 34.2% | ||
| Q2 25 | 8.1% | 16.0% | ||
| Q1 25 | 11.2% | 17.2% | ||
| Q4 24 | 26.8% | 58.2% | ||
| Q3 24 | 27.9% | 12.7% | ||
| Q2 24 | 0.3% | 23.5% | ||
| Q1 24 | -10.4% | -1.4% |
资本支出强度CCELFUSB
| Q4 25 | 0.9% | 31.1% | ||
| Q3 25 | 0.5% | 5.9% | ||
| Q2 25 | 0.8% | 21.8% | ||
| Q1 25 | 0.8% | 0.7% | ||
| Q4 24 | 0.1% | 21.6% | ||
| Q3 24 | 2.3% | 6.6% | ||
| Q2 24 | 21.8% | 2.0% | ||
| Q1 24 | 5.8% | 9.8% |
现金转化率CCELFUSB
| Q4 25 | — | 5.79× | ||
| Q3 25 | 3.38× | 2.18× | ||
| Q2 25 | 1.99× | 25.16× | ||
| Q1 25 | 3.37× | 0.99× | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | 2.32× | 0.87× | ||
| Q2 24 | 2.70× | 1.20× | ||
| Q1 24 | -0.64× | 0.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
